blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3197480

EP3197480 - COMPOSITION TO INDUCE BONE MARROW STEM CELL MOBILIZATION [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  16.12.2022
Database last updated on 13.11.2024
FormerRequest for examination was made
Status updated on  30.06.2017
FormerThe international publication has been made
Status updated on  03.04.2017
Most recent event   Tooltip06.11.2024New entry: Additional fee for renewal fee: despatch of communication + time limit 
Applicant(s)For all designated states
Universita' Degli Studi Di Padova
Via 8 Febbraio 1848, 2
35122 Padova / IT
[2017/31]
Inventor(s)01 / FADINI, Gian Paolo
Via Maestri del lavoro d'Italia
I-35020 Albignasego ( PD ) / IT
02 / ALBIERO, Mattia
Via dei Bersaglieri 3
I-36040 Torri di Quartesolo ( VI ) / IT
03 / CICILIOT, Stefano
Via Roma 87/C
I-35036 Montegrotto Terme ( PD ) / IT
 [2017/31]
Representative(s)Karaghiosoff, Giorgio Alessandro
c/o Praxi Intellectual Property S.p.A. - Savona
Via F. Baracca 1R, 4° piano
"Il Gabbiano"
17100 Savona / IT
[N/P]
Former [2017/31]Karaghiosoff, Giorgio Alessandro
Studio Karaghiosoff e Frizzi S.r.l. Via F. Baracca 1R 4° piano
17100 Savona / IT
Application number, filing date15787296.122.09.2015
[2017/31]
WO2015IB57285
Priority number, dateIT2014GE0009524.09.2014         Original published format: IT GE20140095
[2017/31]
Filing languageIT
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016046738
Date:31.03.2016
Language:EN
[2016/13]
Type: A1 Application with search report 
No.:EP3197480
Date:02.08.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 31.03.2016 takes the place of the publication of the European patent application.
[2017/31]
Search report(s)International search report - published on:EP31.03.2016
ClassificationIPC:A61K38/20, A61P3/10, A61K39/00, C07K16/24
[2017/31]
CPC:
A61K38/193 (EP,US); C07K16/248 (US); A61K31/7088 (EP,US);
A61K31/7105 (EP,US); A61K31/713 (EP,US); A61K39/39541 (US);
A61K39/3955 (US); A61K45/06 (EP,US); A61P3/10 (EP);
C07K16/2866 (US); A61K2039/505 (EP,US); C07K2317/76 (US) (-)
C-Set:
A61K38/193, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/31]
TitleGerman:ZUSAMMENSETZUNG ZUR INDUZIERUNG DER MOBILISIERUNG VON KNOCHENMARKSTAMMZELLEN[2017/31]
English:COMPOSITION TO INDUCE BONE MARROW STEM CELL MOBILIZATION[2017/31]
French:COMPOSITION POUR INDUIRE LA MOBILISATION DES CELLULES SOUCHES DE LA MOELLE OSSEUSE[2017/31]
Entry into regional phase03.04.2017National basic fee paid 
03.04.2017Designation fee(s) paid 
03.04.2017Examination fee paid 
Examination procedure03.04.2017Examination requested  [2017/31]
03.04.2017Date on which the examining division has become responsible
12.10.2017Amendment by applicant (claims and/or description)
20.12.2022Despatch of a communication from the examining division (Time limit: M06)
21.07.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
02.10.2023Reply to a communication from the examining division
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
28.09.2023Request for further processing filed
28.09.2023Full payment received (date of receipt of payment)
Request granted
06.10.2023Decision despatched
Fees paidRenewal fee
28.09.2017Renewal fee patent year 03
24.09.2018Renewal fee patent year 04
30.09.2019Renewal fee patent year 05
30.09.2020Renewal fee patent year 06
17.08.2021Renewal fee patent year 07
14.07.2022Renewal fee patent year 08
25.07.2023Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
30.09.202410   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]  - JOCHEN PÖLING ET AL, "Therapeutic targeting of the oncostatin M receptor-[beta] prevents inflammatory heart failure", BASIC RESEARCH IN CARDIOLOGY, (20140101), vol. 109, no. 1, doi:10.1007/s00395-013-0396-3, ISSN 0300-8428, page 396, XP055143484 [X] 1,2,6-9,11-17,21,23,24 * the whole document * [I] 3-5,10

DOI:   http://dx.doi.org/10.1007/s00395-013-0396-3
 [XI]  - A. CHOW ET AL, "Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche", BLOOD, (20110214), vol. 109, no. 9, doi:10.1182/blood-2006-08-041384, ISSN 0006-4971, pages 3706 - 271, XP055180805 [X] 1,2,6-17,21-25 * the whole document * [I] 18-20

DOI:   http://dx.doi.org/10.1084/jem.20101688
 [X]  - FLOMENBERG N ET AL, "The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, (20050901), vol. 106, no. 5, doi:10.1182/BLOOD-2005-02-0468, ISSN 0006-4971, pages 1867 - 1874, XP002606574 [X] 1,2,6-9,12-17,21-25 * the whole document *

DOI:   http://dx.doi.org/10.1182/BLOOD-2005-02-0468
 [ID]  - KEN-ICHI MINEHATA ET AL, "Oncostatin M Maintains the Hematopoietic Microenvironment and Retains Hematopoietic Progenitors in the Bone Marrow", INTERNATIONAL JOURNAL OF HEMATOLOGY, (20061101), vol. 84, no. 4, doi:10.1532/IJH97.06090, ISSN 0925-5710, pages 319 - 327, XP055180788 [ID] 1-17,21-25 * the whole document *

DOI:   http://dx.doi.org/10.1532/IJH97.06090
 [T]  - RUSUDAN K. HOPMAN ET AL, "Advances in stem cell mobilization", BLOOD REVIEWS, (20140101), vol. 28, no. 1, doi:10.1016/j.blre.2014.01.001, ISSN 0268-960X, pages 31 - 40, XP055153612

DOI:   http://dx.doi.org/10.1016/j.blre.2014.01.001
 [T]  - MATTIA ALBIERO ET AL, "Restoring stem cell mobilization to promote vascular repair in diabetes", VASCULAR PHARMACOLOGY, (20130401), vol. 58, no. 4, doi:10.1016/j.vph.2013.01.003, ISSN 1537-1891, pages 253 - 258, XP055180780

DOI:   http://dx.doi.org/10.1016/j.vph.2013.01.003
by applicantEP0451612
 US5783672
 US5874536
 US5907033
 WO9948523
 EP2643352
    - KISHIMOTO T. ET AL., BLOOD, (1995), vol. 86, pages 1243 - 1254
    - BAKANAY SM ET AL., BONE MARROW TRANSPLANT, (2012), vol. 47, pages 1154 - 1163
    - CHOW A ET AL., J EXP MED, (2011), vol. 208, pages 261 - 271
    - D'ROZARIO J ET AL., TRANSFUS APHER SCI, (2014), vol. 50, pages 443 - 450
    - FADINI GP, DIABETOLOGIA, (2014), vol. 57, pages 4 - 15
    - FADINI GP ET AL., ATHEROSCLEROSIS, (2010), vol. 209, pages 10 - 17
    - FADINI GP ET AL., DIABETES CARE, (2013), vol. 36, pages 943 - 949
    - FADINI GP ET AL., INT J CARDIOL, (2013), vol. 168, pages 892 - 897
    - FADINI GP ET AL., DIABETOLOGIA, (2013), vol. 56, pages 1856 - 1866
    - FADINI GP ET AL., PLOS ONE, (2010), vol. 5, page ELL488
    - FADINI GP ET AL., DIABETOLOGIA, (2006), vol. 49, pages 3075 - 3084
    - FERRARO F ET AL., SCI TRANSL MED, (2011), vol. 3, page 104RA101
    - GUIHARD P ET AL., STEM CELLS, (2012), vol. 30, pages 762 - 772
    - LAPIDOT T ET AL., EXP HEMATOL, (2002), vol. 30, pages 973 - 981
    - LEE MJ ET AL., INT J BIOCHEM CELL BIOL, (2007), vol. 39, pages 650 - 659
    - LEONE AM ET AL., EUR HEART J, (2005), vol. 26, pages 1196 - 1204
    - LEVESQUE JP ET AL., J CLIN INVEST, (2003), vol. 111, pages 187 - 196
    - LING L ET AL., PLOS ONE, (2012), vol. 7, page E50739
    - MINEHATA K ET AL., INT J HEMATOL, (2006), vol. 84, pages 319 - 327
    - MOAZZAMI K ET AL., COCHRANE DATABASE SYST REV, (2013), vol. 5, page CD008844
    - PILLARISETTI S., CARDIOVASC HEMATOL AGENTS MED CHEM, (2012), vol. 10, pages 185 - 189
    - SESHASAI SR ET AL., N ENGL J MED, (2011), vol. 364, pages 829 - 841
    - VAN ROOIJEN N ET AL., J IMMUNOL METHODS, (1994), vol. 174, pages 83 - 93
    - ZIMMET H ET AL., EUR J HEART FAIL, (2012), vol. 14, pages 91 - 105
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.